Skip to main content

Abbott Laboratories(ABT-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Profile

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Key Executives

NameTitle
Mary K. MorelandExecutive VP, Divisional
Robert E. FunckExecutive VP, Divisional
Lisa D. EarnhardtExecutive VP/President, Divisional
Hubert L. AllenExecutive VP/Secretary/General Counsel
Robert B. FordCEO/Chairman of the Board/Director/President
Daniel Gesua Sive SalvadoriExecutive VP/President, Divisional
John A. MccoyChief Accounting Officer/Controller/Vice President, Divisional
Andrea F. WainerExecutive VP, Divisional
Philip P. BoudreauCFO/Senior VP, Divisional
Louis H. MorroneExecutive VP, Divisional